|
|
Sugar and nitrogen
Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: Implications for multiple myeloma.
European journal of immunology
The hemopoietic stem cell niche versus the microenvironment of the multiple myeloma-tumor initiating cell.
Cancer microenvironment : official journal of the International Cancer Microenvironment Society
Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cells.
Gene therapy
Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: implications for multiple myeloma.
European journal of immunology
Novel pyrrolidine ureas as C-C chemokine receptor 1 (CCR1) antagonists.
Journal of medicinal chemistry
Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells.
Molecular oncology
Monoclonal gammopathy associated with multiple myeloma and visceral leishmaniasis in the dog: a comparison of two cases.
Veterinary research communications
Lenalidomide in the treatment of multiple myeloma: a review.
Journal of clinical pharmacy and therapeutics
Inhibition of proliferation and induction of apoptosis in multiple myeloma cell lines by CD137 ligand signaling.
PloS one
The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients.
Experimental hematology
Concurrent diagnoses of Hodgkin lymphoma and biclonal myeloma in the bone marrow.
Annals of diagnostic pathology
Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma.
Leukemia
Chimeric NKG2D receptor-expressing T cells as an immunotherapy for multiple myeloma.
Experimental hematology
Thalidomide and analogues: potential for immunomodulation of inflammatory and neoplastic dermatologic disorders.
Journal of drugs in dermatology : JDD
Two cases of bacterial meningitis accompanied by thalidomide therapy in patients with multiple myeloma: is thalidomide associated with bacterial meningitis?
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
An antibody against RANKL for the treatment of osteoporosis, inflammatory and malignant bone diseases.
Wiener medizinische Wochenschrift (1946)
Role of CCL3 protein (monocyte inflammatory protein-1 alpha) in lymphoid malignancy.
The Egyptian journal of immunology / Egyptian Association of Immunologists
A review of lenalidomide in combination with dexamethasone for the treatment of multiple myeloma.
Therapeutics and clinical risk management
Embelin suppresses osteoclastogenesis induced by receptor activator of NF-? B ligand and tumor cells in vitro through inhibition of the NF-?B Cell signaling pathway.
Molecular cancer research : MCR
Triptolide alters histone H3K9 and H3K27 methylation state and induces G0/G1 arrest and caspase-dependent apoptosis in multiple myeloma in vitro.
Toxicology
European journal of immunology
The hemopoietic stem cell niche versus the microenvironment of the multiple myeloma-tumor initiating cell.
Cancer microenvironment : official journal of the International Cancer Microenvironment Society
Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cells.
Gene therapy
Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: implications for multiple myeloma.
European journal of immunology
Novel pyrrolidine ureas as C-C chemokine receptor 1 (CCR1) antagonists.
Journal of medicinal chemistry
Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells.
Molecular oncology
Monoclonal gammopathy associated with multiple myeloma and visceral leishmaniasis in the dog: a comparison of two cases.
Veterinary research communications
Lenalidomide in the treatment of multiple myeloma: a review.
Journal of clinical pharmacy and therapeutics
Inhibition of proliferation and induction of apoptosis in multiple myeloma cell lines by CD137 ligand signaling.
PloS one
The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients.
Experimental hematology
Concurrent diagnoses of Hodgkin lymphoma and biclonal myeloma in the bone marrow.
Annals of diagnostic pathology
Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma.
Leukemia
Chimeric NKG2D receptor-expressing T cells as an immunotherapy for multiple myeloma.
Experimental hematology
Thalidomide and analogues: potential for immunomodulation of inflammatory and neoplastic dermatologic disorders.
Journal of drugs in dermatology : JDD
Two cases of bacterial meningitis accompanied by thalidomide therapy in patients with multiple myeloma: is thalidomide associated with bacterial meningitis?
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
An antibody against RANKL for the treatment of osteoporosis, inflammatory and malignant bone diseases.
Wiener medizinische Wochenschrift (1946)
Role of CCL3 protein (monocyte inflammatory protein-1 alpha) in lymphoid malignancy.
The Egyptian journal of immunology / Egyptian Association of Immunologists
A review of lenalidomide in combination with dexamethasone for the treatment of multiple myeloma.
Therapeutics and clinical risk management
Embelin suppresses osteoclastogenesis induced by receptor activator of NF-? B ligand and tumor cells in vitro through inhibition of the NF-?B Cell signaling pathway.
Molecular cancer research : MCR
Triptolide alters histone H3K9 and H3K27 methylation state and induces G0/G1 arrest and caspase-dependent apoptosis in multiple myeloma in vitro.
Toxicology
Get breaking news about nutritional cures, dangerous chemicals, superfoods and more.
Subscribe to the FREE Natural News email newsletter. Your privacy is protected.
See more studies on Sugar and...
How is this determined?
The order of these related concepts is determined by a statistical analysis of the scientific literature. Highest-frequency concepts appear first.
|
Glucose 1820 blood 870 Sucrose 859 water 666 Lactose 592 Blood sugar 479 Fructose 478 Galactose 421 Insulin 383 Enzymes 366 diabetes 324 Oligosaccharides 289 ethanol 271 Carbohydrates 257 Fat 250 sodium 249 Glucosamine 237 hydrogen 232 Starch 202 Digestion 184 Beta vulgaris 175 Obesity 168 lead 168 Amino acids 165 nitrogen 164 Nutrition 152 |
Alcohol 142 Tumor 138 Milk 135 salt 129 corn 128 Sorbitol 125 Maltose 122 rice 112 cancer 108 heart 91 Xylitol 82 Seeds 81 Invertase 69 Sweeteners 67 Fluoride 65 beets 60 molasses 59 Vitamin 56 honey 55 Small intestine 55 pollen 43 Asparagine 39 casein 34 Iron 27 wheat 25 |
